secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0001493152-24-005916
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics CEO Kimberly Murphy departs; Pope named Exec Chairman, Redmond Interim PEO
--------------------------------------------------------------------------------

- CEO Kimberly Murphy separated from company Feb 12, 2024, per mutual agreement; remains on board of directors.
- Charlie Pope appointed Executive Chairman, Michael Redmond named Interim Principal Executive Officer immediately.
- Separation provides benefits under employment agreement for termination without cause; no disagreement cited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-005916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer